Targeting oncogenic SOX2 in human cancer cells: therapeutic application

Protein Cell. 2020 Feb;11(2):82-84. doi: 10.1007/s13238-019-00673-x.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cyclopentanes / pharmacology*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology
  • Pyrimidines / pharmacology*
  • SOXB1 Transcription Factors / antagonists & inhibitors*
  • SOXB1 Transcription Factors / genetics
  • SOXB1 Transcription Factors / metabolism

Substances

  • Antineoplastic Agents
  • Cyclopentanes
  • Pyrimidines
  • SOX2 protein, human
  • SOXB1 Transcription Factors
  • pevonedistat